CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | succinic acid |
|
Accession: | CHEBI:15741
|
browse the term
|
Definition: | An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle. |
Synonyms: | related_synonym: | 1,2-ethanedicarboxylic acid; Bernsteinsaeure; Butandisaeure; Butanedionic acid; Dihydrofumaric acid; E363; Ethylenesuccinic acid; Formula=C4H6O4; HOOC-CH2-CH2-COOH; InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8); InChIKey=KDYFGRWQOYBRFD-UHFFFAOYSA-N; SMILES=OC(=O)CCC(O)=O; acide butanedioique; acide succinique; acidum succinicum; amber acid; asuccin; butanedioic acid; spirit of amber |
| alt_id: | CHEBI:22943; CHEBI:26807; CHEBI:45639; CHEBI:9304 |
| xref: | Beilstein:1754069; CAS:110-15-6; DrugBank:DB00139; Drug_Central:2487; ECMDB:ECMDB00254; Gmelin:2785; HMDB:HMDB0000254; KEGG:C00042; KNApSAcK:C00001205; LIPID_MAPS_instance:LMFA01170043 |
| xref_mesh: | MESH:D019802 |
| xref: | MetaCyc:SUC; PDBeChem:SIN; PMID:17439666; Reaxys:1754069; Wikipedia:Succinic_acid; YMDB:YMDB00338 |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:30779 |
|
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases abundance |
ISO |
IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Succinic Acid]; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Succinic Acid] APP protein mutant form results in decreased abundance of Succinic Acid PF-06840003 inhibits the reaction [APP protein mutant form results in decreased abundance of Succinic Acid] |
CTD |
PMID:39172838 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in increased expression of BAX mRNA; [Oleanolic Acid analog binds to Succinic Acid] which results in increased expression of BAX protein |
CTD |
PMID:31401087 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 mRNA; [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 protein |
CTD |
PMID:31401087 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
EXP |
[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid; [geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with Chlorogenic Acid co-treated with crocin co-treated with Flavonoids co-treated with Berberine Alkaloids] inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid]; Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid]; huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with Freund's Adjuvant] results in increased abundance of Succinic Acid] |
CTD |
PMID:24709313 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Dek |
DEK proto-oncogene |
multiple interactions |
ISO |
DEK protein affects the chemical synthesis of and affects the secretion of Succinic Acid |
CTD |
PMID:28558019 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
increases abundance |
ISO |
ERCC6 gene mutant form results in increased abundance of Succinic Acid |
CTD |
PMID:25440059 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
Succinic Acid inhibits the reaction [Rotenone affects the expression of HIF1A protein] |
CTD |
PMID:16034640 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
multiple interactions |
ISO |
IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Succinic Acid] |
CTD |
PMID:39172838 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Lepr |
leptin receptor |
affects abundance |
ISO |
LEPR affects the abundance of Succinic Acid |
CTD |
PMID:20567778 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions decreases abundance |
ISO |
PF-06840003 inhibits the reaction [MAPT protein mutant form results in decreased abundance of Succinic Acid] |
CTD |
PMID:39172838 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of MYC mRNA; [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of MYC protein |
CTD |
PMID:31401087 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of NFKB1 mRNA |
CTD |
PMID:31401087 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
[Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA |
CTD |
PMID:20505214 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Psen1 |
presenilin 1 |
multiple interactions |
ISO |
IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Succinic Acid]; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Succinic Acid] |
CTD |
PMID:39172838 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of PTGS2 mRNA; [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of PTGS2 protein |
CTD |
PMID:31401087 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of RELA mRNA |
CTD |
PMID:31401087 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc13a3 |
solute carrier family 13 member 3 |
affects binding |
ISO EXP |
Succinic Acid binds to SLC13A3 protein |
CTD |
PMID:12397032 |
|
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
|
|
G |
Slc22a19 |
solute carrier family 22, member 19 |
multiple interactions |
EXP |
Succinic Acid affects the reaction [SLC22A19 protein affects the transport of estrone sulfate] |
CTD |
PMID:16079298 |
|
NCBI chr 1:204,910,450...204,965,538
Ensembl chr 1:204,910,455...204,965,538
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
multiple interactions |
EXP |
Succinic Acid inhibits the reaction [SLC22A9 protein affects the transport of estrone sulfate] |
CTD |
PMID:18441515 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions increases activity |
ISO |
[Succinic Acid results in increased activity of SLC22A6 protein] which results in increased uptake of p-Aminohippuric Acid |
CTD |
PMID:36958672 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions increases activity |
ISO |
[Succinic Acid results in increased activity of SLC22A8 protein] which results in increased uptake of p-Aminohippuric Acid |
CTD |
PMID:36958672 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
affects abundance |
ISO |
SLCO1A4 protein affects the abundance of Succinic Acid |
CTD |
PMID:21561886 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of STAT3 mRNA |
CTD |
PMID:31401087 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] Artesunate results in decreased expression of ACTA2 mRNA; Artesunate results in decreased expression of ACTA2 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization |
ISO |
artesunate affects the localization of AIFM1 protein |
CTD |
PMID:24704559 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
Artesunate results in increased expression of ATG12 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
Artesunate results in increased expression of ATG3 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Artesunate results in increased expression of ATG5 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
Artesunate results in increased expression of BAX protein [1,2-Dimethylhydrazine co-treated with artesunate] results in increased expression of BAX protein |
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Artesunate results in decreased expression of BCL2 protein 3-methyladenine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; acadesine promotes the reaction [Artesunate results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased expression of BCL2 protein]; Sirolimus promotes the reaction [Artesunate results in decreased expression of BCL2 protein] [1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein |
CTD |
PMID:24704559 PMID:29031619 PMID:33002460 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
increases response to substance |
ISO |
BST1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
|
|
G |
Casp3 |
caspase 3 |
increases activity increases cleavage multiple interactions |
ISO |
artesunate results in increased activity of CASP3 protein Artesunate results in increased cleavage of CASP3 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of CASP3 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of CASP3 protein] |
CTD |
PMID:19513562 PMID:24704559 PMID:33002460 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
affects expression |
ISO |
artesunate affects the expression of CASP9 protein |
CTD |
PMID:24704559 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression decreases response to substance |
ISO |
artesunate results in increased expression of CAT protein CAT protein results in decreased susceptibility to artesunate |
CTD |
PMID:19513562 PMID:20144594 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
decreases response to substance |
ISO |
CCT2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein] |
CTD |
PMID:31664825 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:31664825 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
increases response to substance |
ISO |
CLIP4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 6:23,616,280...23,697,625 NCBI chr 6:23,718,580...23,729,231 NCBI chr 6:23,597,729...23,601,000
Ensembl chr 6:23,616,281...23,677,874
|
|
G |
Coq8a |
coenzyme Q8A |
decreases response to substance |
ISO |
COQ8A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Dbh |
dopamine beta-hydroxylase |
increases response to substance |
ISO |
DBH mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
|
|
G |
Des |
desmin |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of DES mRNA] Artesunate results in decreased expression of DES mRNA; Artesunate results in decreased expression of DES protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
artesunate results in increased expression of FAS protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Flna |
filamin A |
increases response to substance |
ISO |
FLNA mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of FN1 mRNA] Artesunate results in decreased expression of FN1 mRNA; Artesunate results in decreased expression of FN1 protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fth1 |
ferritin heavy chain 1 |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of FTH1 mRNA; Artesunate results in decreased expression of FTH1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases response to substance |
ISO |
FZD7 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects response to substance decreases response to substance |
ISO |
GCLC mRNA affects the susceptibility to artesunate GCLC mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases response to substance |
ISO |
GCLM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases activity multiple interactions |
ISO |
Artesunate results in decreased activity of GPX4 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX4 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
affects response to substance |
ISO |
GSTM4 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
artesunate results in decreased expression of GSTP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
affects response to substance |
ISO |
GSTT2 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
affects response to substance |
ISO |
GSTZ1 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:31664825 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL6 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases response to substance |
ISO |
ITGB1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases lipidation |
ISO |
3-methyladenine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; dorsomorphin inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] |
CTD |
PMID:33002460 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
affects response to substance |
ISO |
MGST3 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] |
CTD |
PMID:29031619 PMID:30551460 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased activity of MPO protein] |
CTD |
PMID:27474069 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases response to substance |
ISO |
MTHFD2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
acadesine promotes the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein]; dorsomorphin inhibits the reaction [Artesunate results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:33002460 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naca |
nascent polypeptide associated complex subunit alpha |
decreases response to substance |
ISO |
NACA mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:468,862...481,992
Ensembl chr 7:469,723...481,992
|
|
G |
Nckap1 |
NCK-associated protein 1 |
increases response to substance |
ISO |
NCKAP1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:65,417,450...65,491,769
Ensembl chr 3:65,417,453...65,492,217
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA] Artesunate results in decreased expression of NCOA4 mRNA; Artesunate results in decreased expression of NCOA4 protein |
CTD |
PMID:30551460 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization |
ISO |
artesunate affects the localization of NFE2L2 protein |
CTD |
PMID:26340163 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein] |
CTD |
PMID:30031708 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
Artesunate results in increased cleavage of PARP1 protein 3-methyladenine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; acadesine promotes the reaction [Artesunate results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased cleavage of PARP1 protein]; Sirolimus promotes the reaction [Artesunate results in increased cleavage of PARP1 protein] |
CTD |
PMID:24704559 PMID:33002460 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
artesunate binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 mRNA; [Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 protein |
CTD |
PMID:30551460 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of RELA protein]; artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rpa2 |
replication protein A2 |
increases phosphorylation |
ISO |
Artesunate results in increased phosphorylation of RPA2 protein |
CTD |
PMID:31664825 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rpl41 |
ribosomal protein L41 |
decreases response to substance |
ISO |
RPL41 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:977,885...978,965
|
|
G |
Rpl6 |
ribosomal protein L6 |
decreases response to substance |
ISO |
RPL6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
|
|
G |
Rpl7 |
ribosomal protein L7 |
decreases response to substance |
ISO |
RPL7 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:3,217,184...3,220,192
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases response to substance |
ISO |
RPS12 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:21,680,854...21,683,010
Ensembl chr 1:21,680,852...21,683,014
|
|
G |
Rps15a |
ribosomal protein S15a |
decreases response to substance |
ISO |
RPS15A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:172,420,151...172,427,021
Ensembl chr 1:172,419,761...172,426,995
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases response to substance |
ISO |
RPS6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Slc25a19 |
solute carrier family 25 member 19 |
decreases response to substance |
ISO |
SLC25A19 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
|
|
G |
Sp1 |
Sp1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of SP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein] Artesunate results in decreased expression of SQSTM1 mRNA; Artesunate results in decreased expression of SQSTM1 protein |
CTD |
PMID:30551460 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
decreases response to substance |
ISO |
SRSF2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression multiple interactions |
ISO |
Artesunate results in increased expression of TIMP1 mRNA Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of TNF protein]; artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Artesunate results in increased expression of TP53 protein Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] |
CTD |
PMID:33259807 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects response to substance multiple interactions |
ISO |
TPT1 protein affects the susceptibility to artesunate Artesunate binds to and results in decreased expression of TPT1 protein; Artesunate inhibits the reaction [TPT1 protein binds to TP53 protein] |
CTD |
PMID:15878303 PMID:33259807 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
decreases response to substance |
ISO |
TUFM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Ulk1 |
unc-51 like autophagy activating kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Artesunate results in increased phosphorylation of ULK1 protein acadesine promotes the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; Acetylcysteine inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein]; dorsomorphin inhibits the reaction [Artesunate results in increased phosphorylation of ULK1 protein] |
CTD |
PMID:33002460 |
|
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Yy1 |
YY1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of YY1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
increases response to substance |
ISO |
ZBTB4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:54,480,698...54,501,492
Ensembl chr10:54,485,071...54,501,492
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
ISO |
diethyl malate affects the expression of ACTA2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
affects expression |
ISO |
diethyl malate affects the expression of ACTC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:100,811,987...100,817,523
Ensembl chr 3:100,811,987...100,817,523
|
|
G |
Actn3 |
actinin alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ACTN3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:202,159,081...202,175,012
Ensembl chr 1:202,159,082...202,175,012
|
|
G |
Adcy1 |
adenylate cyclase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ADCY1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:81,911,240...82,020,594
Ensembl chr14:81,911,099...82,028,969
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
ISO |
diethyl malate affects the expression of ADH1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Agt |
angiotensinogen |
affects expression |
ISO |
diethyl malate affects the expression of AGT mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
diethyl malate results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
ISO |
diethyl malate results in increased expression of ASF1B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Atp6v1b2 |
ATPase H+ transporting V1 subunit B2 |
increases expression |
ISO |
diethyl malate results in increased expression of ATP6V1B2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
|
|
G |
Bag3 |
BAG cochaperone 3 |
increases expression |
ISO |
diethyl malate results in increased expression of BAG3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bcas2 |
BCAS2, pre-mRNA processing factor |
increases expression |
ISO |
diethyl malate results in increased expression of BCAS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:190,692,503...190,700,386
Ensembl chr 2:190,692,461...190,700,389
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
diethyl malate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
diethyl malate results in increased expression of BRD2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
C3 |
complement C3 |
affects expression |
ISO |
diethyl malate affects the expression of C3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacnb4 |
calcium voltage-gated channel auxiliary subunit beta 4 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CAMK2A mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of CASP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cbr2 |
carbonyl reductase 2 |
affects expression |
ISO |
diethyl malate affects the expression of CBR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
affects expression increases expression |
ISO |
diethyl malate affects the expression of CCL20 mRNA diethyl malate results in increased expression of CCL20 mRNA |
CTD |
PMID:24814887 PMID:38498338 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
affects expression |
ISO |
diethyl malate affects the expression of CCL7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
affects expression |
ISO |
diethyl malate affects the expression of CCL6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
diethyl malate results in increased expression of CTGF mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
diethyl malate results in increased expression of CCNE2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CDK5R1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CHAC1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression |
ISO |
diethyl malate results in increased expression of CIDEC mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
diethyl malate results in increased expression of CKS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clk1 |
CDC-like kinase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CLK1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 9:59,947,774...59,959,002
Ensembl chr 9:59,947,764...59,957,000
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL11A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL2A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL3A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL6A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Comp |
cartilage oligomeric matrix protein |
affects expression |
ISO |
diethyl malate affects the expression of COMP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
ISO |
diethyl malate results in increased expression of CSRNP1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of CXCL12 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CXCL12 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
affects expression |
ISO |
diethyl malate affects the expression of CXCL1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
affects expression |
ISO |
diethyl malate affects the expression of CXCL5 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
ISO |
diethyl malate affects the expression of CYP2J9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
increases expression |
ISO |
diethyl malate results in increased expression of CYP4F3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr16:17,763,543...17,804,944
Ensembl chr16:17,707,317...17,804,940
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
affects expression |
ISO |
diethyl malate affects the expression of DAPK2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:66,706,536...66,825,567
Ensembl chr 8:66,706,609...66,825,567
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
diethyl malate results in increased expression of DDIT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
affects expression |
ISO |
diethyl malate affects the expression of DHRS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
affects expression |
ISO |
diethyl malate affects the expression of DHX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
diethyl malate results in increased expression of DNAJB4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Edar |
ectodysplasin-A receptor |
affects expression |
ISO |
diethyl malate affects the expression of EDAR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:26,587,836...26,666,543
Ensembl chr20:26,587,839...26,666,494
|
|
G |
Ednra |
endothelin receptor type A |
affects expression |
ISO |
diethyl malate affects the expression of EDNRA mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Emg1 |
EMG1 N1-specific pseudouridine methyltransferase |
increases expression |
ISO |
diethyl malate results in increased expression of EMG1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
diethyl malate results in increased expression of ENO2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of EPAS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha7 |
Eph receptor A7 |
affects expression |
ISO |
diethyl malate affects the expression of EPHA7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
|
|
G |
Ephb2 |
Eph receptor B2 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
increases expression |
ISO |
diethyl malate results in increased expression of FAM83D mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects expression |
ISO |
diethyl malate affects the expression of FGF10 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of FGF18 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FGFR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
diethyl malate results in increased expression of FOSL1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fst |
follistatin |
affects expression |
ISO |
diethyl malate affects the expression of FST mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FZD2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
Fzd7 |
frizzled class receptor 7 |
affects expression |
ISO |
diethyl malate affects the expression of FZD7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
diethyl malate results in increased expression of G6PD mRNA |
CTD |
PMID:38498338 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
ISO |
diethyl malate affects the expression of GCLC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
diethyl malate results in increased expression of GCNT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
affects expression |
ISO |
diethyl malate affects the expression of GGT6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:57,051,977...57,054,900
Ensembl chr10:57,051,825...57,067,260
|
|
G |
Gli2 |
GLI family zinc finger 2 |
affects expression |
ISO |
diethyl malate affects the expression of GLI2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
affects expression |
ISO |
diethyl malate affects the expression of GNAO1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
|
|
G |
Gng7 |
G protein subunit gamma 7 |
affects expression |
ISO |
diethyl malate affects the expression of GNG7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Gnpda1 |
glucosamine-6-phosphate deaminase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of GNPDA1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr18:30,165,435...30,177,462
Ensembl chr18:30,165,427...30,177,486
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of GPAT3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gsr |
glutathione-disulfide reductase |
affects expression |
ISO |
diethyl malate affects the expression of GSR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSS mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of GSTA1 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA1 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1B1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H2ac4 |
H2A clustered histone 4 |
increases expression |
ISO |
diethyl malate results in increased expression of HIST1H2AC mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
affects expression |
ISO |
diethyl malate affects the expression of HCK mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hgf |
hepatocyte growth factor |
affects expression |
ISO |
diethyl malate affects the expression of HGF mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
increases expression |
ISO |
diethyl malate results in increased expression of HIST1H2BD mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:42,792,887...42,793,268
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
increases expression |
ISO |
diethyl malate results in increased expression of HMGCS2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
ISO |
diethyl malate results in increased expression of HMMR mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of HMOX1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
ISO |
diethyl malate results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA1A mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA1B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
diethyl malate results in increased expression of HSPA8 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
increases expression |
ISO |
diethyl malate results in increased expression of IFRD1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
ISO |
diethyl malate affects the expression of IGF1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
diethyl malate results in increased expression of IGFBP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Il15 |
interleukin 15 |
affects expression |
ISO |
diethyl malate affects the expression of IL15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il18 |
interleukin 18 |
affects expression |
ISO |
diethyl malate affects the expression of IL18 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
affects expression |
ISO |
diethyl malate affects the expression of IRAG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:164,981,716...165,094,232
Ensembl chr 1:164,981,716...165,094,176
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects expression |
ISO |
diethyl malate affects the expression of IRF7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects expression |
ISO |
diethyl malate affects the expression of ISG15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
|
|
G |
Itga11 |
integrin subunit alpha 11 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA11 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:63,145,998...63,254,714
Ensembl chr 8:63,146,001...63,254,407
|
|
G |
Itga3 |
integrin subunit alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
increases expression |
ISO |
diethyl malate results in increased expression of JMJD6 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Kcnmb4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
affects expression |
ISO |
diethyl malate affects the expression of KCNMB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:52,066,145...52,119,098
Ensembl chr 7:52,066,136...52,119,278
|
|
G |
Lama1 |
laminin subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Lama4 |
laminin subunit alpha 4 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
diethyl malate results in increased expression of MAFF mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
diethyl malate results in increased expression of MAFG mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
diethyl malate results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK1 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:24814887 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK3 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:24814887 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
diethyl malate results in increased expression of MMP1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of MMP3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Myl4 |
myosin, light chain 4 |
increases expression |
ISO |
diethyl malate results in increased expression of MYL4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr10:89,449,456...89,485,365
Ensembl chr10:89,449,443...89,485,363
|
|
G |
Myl9 |
myosin light chain 9 |
affects expression |
ISO |
diethyl malate affects the expression of MYL9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
increases expression |
ISO |
diethyl malate results in increased expression of NDRG1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ODC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
ISO |
diethyl malate results in increased expression of OSGIN1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of PDGFB mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of PDGFB mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfd |
platelet derived growth factor D |
affects expression |
ISO |
diethyl malate affects the expression of PDGFD mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
G |
Pf4 |
platelet factor 4 |
affects expression |
ISO |
diethyl malate affects the expression of PF4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
increases expression |
ISO |
diethyl malate results in increased expression of PFKFB4 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
|
|
G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of PIK3IP1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
|
|
G |
Plin2 |
perilipin 2 |
increases expression |
ISO |
diethyl malate results in increased expression of PLIN2 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plxnc1 |
plexin C1 |
affects expression |
ISO |
diethyl malate affects the expression of PLXNC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:29,390,038...29,543,985
Ensembl chr 7:29,390,048...29,543,779
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
diethyl malate results in increased expression of PPP1R15A mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
affects expression |
ISO |
diethyl malate affects the expression of PRKG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
|
|
G |
Ptgis |
prostaglandin I2 synthase |
affects expression |
ISO |
diethyl malate affects the expression of PTGIS mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
affects expression |
ISO |
diethyl malate affects the expression of RAMP2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
affects expression |
ISO |
diethyl malate affects the expression of RGS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
|
|
G |
Rig1 |
RNA sensor RIG-1 |
affects expression |
ISO |
diethyl malate affects the expression of RIGI mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
RT1-DMb |
RT1 class II, locus DMb |
affects expression |
ISO |
diethyl malate affects the expression of H2-DMB1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
affects expression |
ISO |
diethyl malate affects the expression of H2-M3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Runx1t1 |
RUNX1 partner transcriptional co-repressor 1 |
affects expression |
ISO |
diethyl malate affects the expression of RUNX1T1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592
|
|
G |
Sema3b |
semaphorin 3B |
affects expression |
ISO |
diethyl malate affects the expression of SEMA3B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:108,271,663...108,280,326
Ensembl chr 8:108,271,666...108,282,919
|
|
G |
Sema4g |
semaphorin 4G |
affects expression |
ISO |
diethyl malate affects the expression of SEMA4G mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
|
|
G |
Sema5a |
semaphorin 5A |
affects expression |
ISO |
diethyl malate affects the expression of SEMA5A mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
diethyl malate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
diethyl malate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
diethyl malate results in increased expression of SRXN1 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
affects expression |
ISO |
diethyl malate affects the expression of STAT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
increases expression |
ISO |
diethyl malate results in increased expression of TACC3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
|
|
G |
Tes |
testin LIM domain protein |
increases expression |
ISO |
diethyl malate results in increased expression of TES mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of TGFB2 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of TGFB2 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Thbs1 |
thrombospondin 1 |
affects expression |
ISO |
diethyl malate affects the expression of THBS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Thbs2 |
thrombospondin 2 |
affects expression |
ISO |
diethyl malate affects the expression of THBS2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789
|
|
G |
Tnc |
tenascin C |
affects expression |
ISO |
diethyl malate affects the expression of TNC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
affects expression |
ISO |
diethyl malate affects the expression of TNFRSF11B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
affects expression |
ISO |
diethyl malate affects the expression of TNNT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
diethyl malate results in increased expression of TRIB3 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tslp |
thymic stromal lymphopoietin |
affects expression |
ISO |
diethyl malate affects the expression of TSLP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
diethyl malate results in increased expression of VEGFA mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Zbtb21 |
zinc finger and BTB domain containing 21 |
increases expression |
ISO |
diethyl malate results in increased expression of ZBTB21 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr11:37,312,337...37,327,040
Ensembl chr11:37,312,378...37,326,996
|
|
G |
Zfp110 |
zinc finger protein 110 |
increases expression |
ISO |
diethyl malate results in increased expression of ZNF274 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086
|
|
G |
Zfp367 |
zinc finger protein 367 |
increases expression |
ISO |
diethyl malate results in increased expression of ZNF367 mRNA |
CTD |
PMID:38498338 |
|
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[hydrocortisone hemisuccinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP1A2 |
CTD |
PMID:18347083 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[hydrocortisone hemisuccinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP3A4 |
CTD |
PMID:18347083 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
F2 |
coagulation factor II, thrombin |
affects expression |
ISO |
hydrocortisone hemisuccinate affects the expression of F2 protein |
CTD |
PMID:12542493 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Il18 |
interleukin 18 |
decreases secretion |
ISO |
hydrocortisone hemisuccinate results in decreased secretion of IL18 protein |
CTD |
PMID:20421217 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
decreases secretion |
ISO |
hydrocortisone hemisuccinate results in decreased secretion of IL1B protein |
CTD |
PMID:20421217 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases secretion |
ISO |
hydrocortisone hemisuccinate results in decreased secretion of IL6 protein |
CTD |
PMID:20421217 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion |
ISO |
hydrocortisone hemisuccinate results in decreased secretion of TNF protein |
CTD |
PMID:20421217 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Acbd5 |
acyl-CoA binding domain containing 5 |
increases expression |
ISO |
Malathion results in increased expression of ACBD5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:85,206,178...85,248,909
Ensembl chr17:85,206,303...85,248,215
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases activity |
ISO EXP |
[Malathion co-treated with Dichlorvos] results in decreased activity of ACHE protein; Obidoxime Chloride inhibits the reaction [Malathion results in decreased activity of ACHE protein]; Oximes analog inhibits the reaction [Malathion results in decreased activity of ACHE protein]; pralidoxime inhibits the reaction [Malathion results in decreased activity of ACHE protein] [Endosulfan co-treated with Malathion] results in decreased activity of ACHE protein; [Malathion co-treated with Permethrin] results in decreased activity of ACHE protein; [Malathion co-treated with Permethrin] results in increased activity of ACHE protein; Taurine inhibits the reaction [Malathion results in decreased activity of ACHE protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of ACHE protein] |
CTD |
PMID:2380476 PMID:4859365 PMID:14713564 PMID:18617161 PMID:19429256 PMID:19784758 PMID:21628957 PMID:21723318 PMID:21983245 PMID:23774768 PMID:28987951 PMID:30625376 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot6 |
acyl-CoA thioesterase 6 |
decreases expression |
ISO |
Malathion results in decreased expression of ACOT6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:103,732,372...103,741,446
Ensembl chr 6:103,732,372...103,741,446
|
|
G |
Acsm1 |
acyl-CoA synthetase medium-chain family member 1 |
decreases expression |
ISO |
Malathion results in decreased expression of ACSM1 mRNA |
CTD |
PMID:17311802 |
|
NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
|
|
G |
Adam11 |
ADAM metallopeptidase domain 11 |
increases methylation |
ISO |
Malathion results in increased methylation of ADAM11 promoter |
CTD |
PMID:37047231 |
|
NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562
|
|
G |
Adam32 |
ADAM metallopeptidase domain 32 |
decreases expression |
ISO |
Malathion results in decreased expression of ADAM32 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:67,102,384...67,212,163
Ensembl chr16:67,102,320...67,212,161
|
|
G |
Adamts12 |
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
decreases expression |
ISO |
Malathion results in decreased expression of ADAMTS12 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:60,032,873...60,327,629
Ensembl chr 2:60,032,873...60,327,629
|
|
G |
Adamts20 |
ADAM metallopeptidase with thrombospondin type 1 motif, 20 |
decreases expression |
ISO |
Malathion results in decreased expression of ADAMTS20 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:125,396,227...125,528,020
Ensembl chr 7:125,397,734...125,527,777
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
increases expression |
ISO |
Malathion results in increased expression of ADAMTS6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
|
|
G |
Add3 |
adducin 3 |
increases expression |
EXP |
Malathion results in increased expression of ADD3 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Malathion results in increased expression of ADM mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
increases expression |
ISO |
Malathion results in increased expression of ADRA2A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Aff1 |
ALF transcription elongation factor 1 |
increases expression |
ISO |
Malathion results in increased expression of AFF1 mRNA mutant form |
CTD |
PMID:28624474 |
|
NCBI chr14:5,861,188...6,024,196
Ensembl chr14:5,863,961...6,024,729
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
[prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with Malathion] results in increased activity of AHR protein |
CTD |
PMID:25684042 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Malathion results in increased expression of AKR1C1 mRNA |
CTD |
PMID:16079077 PMID:18214805 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Malathion results in increased expression of AKR1C2 mRNA |
CTD |
PMID:16079077 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1e2 |
aldo-keto reductase family 1, member E2 |
decreases expression |
ISO |
Malathion results in decreased expression of AKR1E2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:65,735,909...65,750,441
Ensembl chr17:65,735,943...65,750,441
|
|
G |
Alkal2 |
ALK and LTK ligand 2 |
increases expression |
ISO |
Malathion results in increased expression of ALKAL2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:47,495,645...47,505,235
Ensembl chr 6:47,495,782...47,505,234
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases activity multiple interactions |
EXP |
Malathion results in increased activity of ALPL protein thymoquinone inhibits the reaction [Malathion results in increased activity of ALPL protein] |
CTD |
PMID:33510276 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amot |
angiomotin |
decreases expression |
ISO |
Malathion results in decreased expression of AMOT mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:108,982,399...109,041,265
Ensembl chr X:108,984,022...109,041,272
|
|
G |
Angptl2 |
angiopoietin-like 2 |
decreases expression |
ISO |
Malathion results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases methylation increases expression |
ISO |
Malathion results in decreased methylation of ANGPTL4 promoter Malathion results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ank1 |
ankyrin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of ANK1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:68,876,294...69,054,963
Ensembl chr16:68,877,504...69,054,759
|
|
G |
Ankrd55 |
ankyrin repeat domain 55 |
increases expression |
ISO |
Malathion results in increased expression of ANKRD55 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
|
|
G |
Aplf |
aprataxin and PNKP like factor |
decreases expression |
ISO |
Malathion results in decreased expression of APLF mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Aqp12a |
aquaporin 12A |
decreases expression |
ISO |
Malathion results in decreased expression of AQP12A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:93,554,527...93,560,011
Ensembl chr 9:93,554,527...93,560,011
|
|
G |
Aqp9 |
aquaporin 9 |
increases expression |
ISO |
Malathion results in increased expression of AQP9 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO EXP |
[terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; [terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] results in decreased activity of AR protein Malathion results in decreased expression of AR mRNA |
CTD |
PMID:23871939 PMID:36336997 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Armc3 |
armadillo repeat containing 3 |
decreases expression |
ISO |
Malathion results in decreased expression of ARMC3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:81,814,087...81,917,534
Ensembl chr17:81,832,518...81,917,531
|
|
G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
decreases expression |
ISO |
Malathion results in decreased expression of ARNT2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
|
|
G |
Asic5 |
acid sensing ion channel subunit family member 5 |
increases expression |
ISO |
Malathion results in increased expression of ASIC5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:167,307,984...167,336,812
Ensembl chr 2:167,307,984...167,336,812
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
ISO |
Malathion results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of B4GALT1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B9d1 |
B9 domain containing 1 |
decreases expression |
ISO |
Malathion results in decreased expression of B9D1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression increases expression multiple interactions |
EXP ISO |
Malathion results in decreased expression of BAX mRNA Malathion results in increased expression of BAX protein crocin inhibits the reaction [Malathion results in increased expression of BAX protein] Plant Extracts inhibits the reaction [Malathion results in increased expression of BAX protein]; Polyphenols inhibits the reaction [Malathion results in increased expression of BAX protein] Acetylcysteine inhibits the reaction [Malathion results in increased expression of BAX protein] |
CTD |
PMID:23774768 PMID:30769050 PMID:32120800 PMID:35274200 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions increases activity decreases activity |
ISO EXP |
Obidoxime Chloride inhibits the reaction [Malathion results in decreased activity of BCHE protein] Malathion results in increased activity of BCHE protein |
CTD |
PMID:17364237 PMID:18617161 PMID:21983245 PMID:25180440 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression multiple interactions |
EXP ISO |
Malathion results in decreased expression of BCL2 mRNA Malathion results in increased expression of BCL2 mRNA Malathion results in increased expression of BCL2 protein Acetylcysteine inhibits the reaction [Malathion results in decreased expression of BCL2 protein] |
CTD |
PMID:23774768 PMID:30673264 PMID:30769050 PMID:32120800 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[Pesticides results in increased abundance of Malathion metabolite] which results in decreased secretion of BDNF protein; [Pesticides results in increased abundance of Malathion metabolite] which results in increased methylation of BDNF gene |
CTD |
PMID:35292247 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression multiple interactions |
EXP |
Malathion results in increased expression of BIRC5 protein Rosmarinic Acid inhibits the reaction [Malathion results in increased expression of BIRC5 protein]; thymoquinone inhibits the reaction [Malathion results in increased expression of BIRC5 protein] |
CTD |
PMID:33510276 PMID:34262720 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
increases expression |
ISO |
Malathion results in increased expression of BMI1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Brd7 |
bromodomain containing 7 |
increases expression |
ISO |
Malathion results in increased expression of BRD7 mRNA |
CTD |
PMID:18214912 |
|
NCBI chr19:18,708,792...18,737,497
Ensembl chr19:18,709,022...18,737,494
|
|
G |
Bsnd |
barttin CLCNK type accessory subunit beta |
increases expression |
ISO |
Malathion results in increased expression of BSND mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
|
|
G |
Btg1 |
BTG anti-proliferation factor 1 |
decreases expression |
ISO |
Malathion results in decreased expression of BTG1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Malathion results in decreased expression of BUB1 mRNA |
CTD |
PMID:16079077 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
C16h10orf53 |
similar to human chromosome 10 open reading frame 53 |
decreases expression |
ISO |
Malathion results in decreased expression of C10ORF53 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:7,634,207...7,644,876
Ensembl chr16:7,634,207...7,644,876
|
|
G |
C1ql2 |
complement C1q like 2 |
decreases expression |
ISO |
Malathion results in decreased expression of C1QL2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:31,471,150...31,472,685
Ensembl chr13:31,471,150...31,472,689
|
|
G |
C2h3orf80 |
similar to human chromosome 3 open reading frame 80 |
decreases expression |
ISO |
Malathion results in decreased expression of C3ORF80 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:153,125,312...153,128,124
Ensembl chr 2:153,125,676...153,126,419
|
|
G |
C3h11orf96 |
similar to human chromosome 11 open reading frame 96 |
increases expression |
ISO |
Malathion results in increased expression of C11ORF96 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:79,920,125...79,921,368
Ensembl chr 3:79,920,129...79,921,523
|
|
G |
C3h15orf48 |
similar to human chromosome 15 open reading frame 48 |
increases expression |
ISO |
Malathion results in increased expression of C15ORF48 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:109,719,897...109,724,006 Ensembl chr 3:109,719,897...109,724,006
|
|
G |
C5h8orf34 |
similar to human chromosome 8 open reading frame 34 |
decreases expression |
ISO |
Malathion results in decreased expression of C8ORF34 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:7,237,968...7,777,119
Ensembl chr 5:7,238,853...7,776,769
|
|
G |
C7h12orf54 |
similar to human chromosome 12 open reading frame 54 |
decreases expression |
ISO |
Malathion results in decreased expression of C12ORF54 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:129,529,811...129,548,676
|
|
G |
Cabp7 |
calcium binding protein 7 |
decreases expression |
ISO |
Malathion results in decreased expression of CABP7 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:79,598,822...79,609,172
Ensembl chr14:79,598,827...79,609,240
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
increases expression |
ISO |
Malathion results in increased expression of CACNA1C mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions |
EXP |
Malathion promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
multiple interactions |
EXP |
Malathion promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capn8 |
calpain 8 |
decreases expression |
ISO |
Malathion results in decreased expression of CAPN8 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
|
|
G |
Cartpt |
CART prepropeptide |
increases expression |
ISO |
Malathion results in increased expression of CARTPT mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp3 |
caspase 3 |
increases activity increases cleavage multiple interactions increases expression |
ISO EXP |
Malathion results in increased activity of CASP3 protein Malathion results in increased cleavage of CASP3 protein Malathion results in increased activity of and results in increased cleavage of CASP3 protein; Metoclopramide inhibits the reaction [Malathion results in increased activity of and results in increased cleavage of CASP3 protein] Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP3 protein] Malathion results in increased expression of CASP3 mRNA [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; crocin inhibits the reaction [Malathion results in increased cleavage of CASP3 protein]; Levodopa inhibits the reaction [Malathion results in increased cleavage of CASP3 protein] |
CTD |
PMID:12505448 PMID:19815060 PMID:21628957 PMID:27941166 PMID:29027213 PMID:30769050 PMID:35274200 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
decreases expression |
ISO |
Malathion results in decreased expression of CASP4 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Malathion results in increased activity of CASP8 protein |
CTD |
PMID:12505448 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity increases cleavage multiple interactions increases expression |
ISO EXP |
Malathion results in increased activity of CASP9 protein Malathion results in increased cleavage of CASP9 protein Acetylcysteine inhibits the reaction [Malathion results in increased cleavage of CASP9 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; crocin inhibits the reaction [Malathion results in increased cleavage of CASP9 protein]; Levodopa inhibits the reaction [Malathion results in increased cleavage of CASP9 protein] |
CTD |
PMID:12505448 PMID:21628957 PMID:27941166 PMID:30769050 PMID:35274200 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases expression decreases activity increases activity |
EXP ISO |
[Dimethoate co-treated with Malathion] results in increased activity of CAT protein; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; Pentoxifylline inhibits the reaction [Malathion results in increased activity of CAT protein]; Taurine inhibits the reaction [Malathion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of CAT protein] Malathion results in decreased expression of CAT protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; Acetylcysteine inhibits the reaction [Malathion results in decreased activity of CAT protein]; Ascorbic Acid inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein] [Malathion co-treated with 1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide] results in increased activity of CAT protein; [Malathion co-treated with pralidoxime] results in increased activity of CAT protein; lavender oil inhibits the reaction [Malathion results in decreased expression of CAT protein]; Plant Extracts inhibits the reaction [Malathion results in decreased activity of CAT protein]; Polyphenols inhibits the reaction [Malathion results in decreased activity of CAT protein] |
CTD |
PMID:11834209 PMID:18655177 PMID:19429256 PMID:20194575 PMID:21628957 PMID:21723318 PMID:24810974 PMID:25180440 PMID:28987951 PMID:30409133 PMID:30673264 PMID:30769050 PMID:32120800 PMID:36336997 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbfb |
core-binding factor subunit beta |
increases expression |
ISO |
Malathion results in increased expression of CBFB mRNA |
CTD |
PMID:32069766 |
|
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
|
|
G |
Ccdc126 |
coiled-coil domain containing 126 |
increases expression |
ISO |
Malathion results in increased expression of CCDC126 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:78,297,625...78,318,655
Ensembl chr 4:78,297,551...78,318,655
|
|
G |
Cck |
cholecystokinin |
increases expression |
EXP |
Malathion results in increased expression of CCK mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
increases expression |
ISO |
Malathion results in increased expression of CCL1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
increases expression |
ISO |
Malathion results in increased expression of CCL19 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Malathion results in increased expression of CCL20 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
Malathion results in increased expression of CCL3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
Malathion results in increased expression of CCL7 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccm2l |
CCM2 like scaffold protein |
increases expression |
ISO |
Malathion results in increased expression of CCM2L mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Malathion results in decreased expression of CCNA2 protein |
CTD |
PMID:30769050 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Malathion results in decreased expression of CCNB1 protein |
CTD |
PMID:30769050 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
Malathion results in decreased expression of CCNE1 protein |
CTD |
PMID:30769050 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccser1 |
coiled-coil serine-rich protein 1 |
increases expression |
ISO |
Malathion results in increased expression of CCSER1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:90,153,873...91,391,441
Ensembl chr 4:90,292,780...91,388,786
|
|
G |
Cd14 |
CD14 molecule |
decreases expression |
ISO |
Malathion results in decreased expression of CD14 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
Malathion results in increased expression of CD274 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
ISO |
Malathion results in increased expression of CD36 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd5 |
Cd5 molecule |
decreases expression |
ISO |
Malathion results in decreased expression of CD5 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
|
|
G |
Cd69 |
Cd69 molecule |
increases expression |
ISO |
Malathion results in increased expression of CD69 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
Malathion results in decreased expression of CDC20 mRNA |
CTD |
PMID:18214805 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdk15 |
cyclin-dependent kinase 15 |
increases expression |
ISO |
Malathion results in increased expression of CDK15 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:60,710,787...60,803,638
Ensembl chr 9:60,711,715...60,802,777
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression increases expression |
ISO |
Malathion results in decreased expression of CDK2 protein Malathion results in increased expression of CDK2 mRNA |
CTD |
PMID:30769050 PMID:32069766 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
increases expression |
ISO |
Malathion results in increased expression of CEBPG mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
Malathion results in decreased expression of CENPF mRNA |
CTD |
PMID:16079077 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
Malathion results in increased expression of CES1 mRNA |
CTD |
PMID:17311802 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfap157 |
cilia and flagella associated protein 157 |
decreases expression |
ISO |
Malathion results in decreased expression of CFAP157 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:16,066,521...16,073,504
Ensembl chr 3:16,066,521...16,073,495
|
|
G |
Cfap91 |
cilia and flagella associated protein 91 |
decreases expression |
ISO |
Malathion results in decreased expression of CFAP91 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:62,413,613...62,457,281
Ensembl chr11:62,413,602...62,457,293
|
|
G |
Cfb |
complement factor B |
increases expression |
ISO |
Malathion results in increased expression of CFB mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Ch25h |
cholesterol 25-hydroxylase |
increases expression |
ISO |
Malathion results in increased expression of CH25H mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
|
|
G |
Cldn12 |
claudin 12 |
increases expression |
ISO |
Malathion results in increased expression of CLDN12 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:28,522,659...28,533,647
Ensembl chr 4:28,522,678...28,533,801
|
|
G |
Cldn22 |
claudin 22 |
decreases expression |
ISO |
Malathion results in decreased expression of CLDN22 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:44,422,344...44,423,370
Ensembl chr16:44,422,345...44,423,354
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions decreases expression |
EXP |
[Malathion co-treated with Lead] results in decreased expression of CLDN5 protein Malathion results in decreased expression of CLDN5 protein |
CTD |
PMID:20970449 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Cma1 |
chymase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of CMA1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
|
|
G |
Cntn4 |
contactin 4 |
increases expression |
ISO |
Malathion results in increased expression of CNTN4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
Malathion results in increased expression of COL1A2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Cpne9 |
copine family member 9 |
decreases expression |
ISO |
Malathion results in decreased expression of CPNE9 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:146,429,961...146,454,335
Ensembl chr 4:146,430,792...146,454,333
|
|
G |
Cpz |
carboxypeptidase Z |
decreases expression |
ISO |
Malathion results in decreased expression of CPZ mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions decreases expression |
EXP |
caffeic acid inhibits the reaction [Malathion results in decreased expression of CRH mRNA] |
CTD |
PMID:20233601 PMID:25404496 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crisp3 |
cysteine-rich secretory protein 3 |
decreases expression |
ISO |
Malathion results in decreased expression of CRISP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:20,432,051...20,472,663
Ensembl chr 9:20,450,908...20,472,658
|
|
G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
decreases expression |
EXP |
Malathion results in decreased expression of CRISPLD2 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
|
|
G |
Csf2 |
colony stimulating factor 2 |
increases expression |
EXP ISO |
Malathion results in increased expression of CSF2 protein Malathion results in increased expression of CSF2 mRNA |
CTD |
PMID:34778934 PMID:37047231 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
ISO |
Malathion results in increased expression of CSF3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
Malathion results in increased expression of CTSD protein |
CTD |
PMID:8812242 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
ISO |
Malathion results in increased expression of CXCL11 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions increases expression |
ISO |
Plant Extracts inhibits the reaction [Malathion results in increased expression of CYBB protein]; Polyphenols inhibits the reaction [Malathion results in increased expression of CYBB protein] |
CTD |
PMID:32120800 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO |
Malathion results in decreased expression of CYP11A1 mRNA lavender oil inhibits the reaction [Malathion results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:30409133 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA |
CTD |
PMID:23954766 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects metabolic processing increases expression |
ISO |
CYP1A2 protein affects the metabolism of Malathion Malathion results in increased expression of CYP1A2 mRNA |
CTD |
PMID:15557345 PMID:22310298 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
ISO |
Malathion results in increased expression of CYP27B1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
affects metabolic processing multiple interactions increases expression decreases activity |
ISO |
CYP2B6 protein affects the metabolism of Malathion Malathion promotes the reaction [isomalathion results in increased expression of CYP2B6 mRNA] Malathion results in increased expression of CYP2B6 mRNA Malathion results in decreased activity of CYP2B6 protein |
CTD |
PMID:15557345 PMID:22310298 PMID:24333466 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Malathion inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] Malathion results in decreased activity of CYP2E1 protein |
CTD |
PMID:22634058 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression affects metabolic processing |
ISO |
[Malathion co-treated with isomalathion] results in increased expression of CYP3A4 mRNA Malathion results in increased expression of CYP3A4 mRNA CYP3A4 protein affects the metabolism of Malathion |
CTD |
PMID:15557345 PMID:17110060 PMID:22310298 PMID:24333466 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects metabolic processing increases expression |
ISO |
CYP3A5 protein affects the metabolism of Malathion Malathion results in increased expression of CYP3A5 mRNA |
CTD |
PMID:17110060 PMID:37047231 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
multiple interactions |
ISO |
[Insecticides results in increased abundance of Malathion] which affects the methylation of CYP8B1 gene |
CTD |
PMID:34516295 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Dcn |
decorin |
increases expression |
ISO |
Malathion results in increased expression of DCN mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Ddc |
dopa decarboxylase |
affects binding increases expression |
ISO |
Malathion binds to [DDC protein binds to Pyridoxal Phosphate]; Malathion binds to DDC protein Malathion results in increased expression of DDC mRNA |
CTD |
PMID:35151785 PMID:37047231 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of DDR1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Ddx11 |
DEAD/H-box helicase 11 |
increases expression |
ISO |
Malathion results in increased expression of DDX11 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of DIO1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Disc1 |
DISC1 scaffold protein |
increases expression |
ISO |
Malathion results in increased expression of DISC1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
|
|
G |
Dkk2 |
dickkopf WNT signaling pathway inhibitor 2 |
increases expression |
ISO |
Malathion results in increased expression of DKK2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:220,568,338...220,660,225
Ensembl chr 2:220,568,338...220,660,225
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases expression |
ISO |
Malathion results in increased expression of DLG2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
EXP |
Malathion results in decreased expression of DNMT1 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
affects expression |
EXP |
Malathion affects the expression of DNMT3A mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
affects expression |
EXP |
Malathion affects the expression of DNMT3B mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Doc2b |
double C2 domain beta |
decreases expression |
ISO |
Malathion results in decreased expression of DOC2B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:60,628,029...60,653,267
Ensembl chr10:60,628,029...60,653,267
|
|
G |
Dsp |
desmoplakin |
increases expression |
ISO |
Malathion results in increased expression of DSP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Dspp |
dentin sialophosphoprotein |
decreases expression |
ISO |
Malathion results in decreased expression of DSPP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
|
|
G |
Dtna |
dystrobrevin, alpha |
decreases expression |
ISO |
Malathion results in decreased expression of DTNA mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
|
|
G |
Duox1 |
dual oxidase 1 |
multiple interactions increases expression |
ISO |
Plant Extracts inhibits the reaction [Malathion results in increased expression of DUOX1 protein]; Polyphenols inhibits the reaction [Malathion results in increased expression of DUOX1 protein] |
CTD |
PMID:32120800 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of DUSP1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
Malathion results in increased expression of DUSP5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dvl1 |
dishevelled segment polarity protein 1 |
increases expression |
ISO |
Malathion results in increased expression of DVL1 mRNA |
CTD |
PMID:18204794 |
|
NCBI chr 5:166,456,989...166,468,733
Ensembl chr 5:166,456,686...166,468,664
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
increases expression |
ISO |
Malathion results in increased expression of EBI3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
Malathion results in increased expression of EDN1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednrb |
endothelin receptor type B |
decreases expression |
ISO |
Malathion results in decreased expression of EDNRB mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Efcab9 |
EF-hand calcium binding domain 9 |
increases expression |
ISO |
Malathion results in increased expression of EFCAB9 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:17,107,123...17,112,282
Ensembl chr10:17,107,123...17,112,289
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
increases response to substance |
ISO |
EHBP1 gene SNP results in increased susceptibility to Malathion |
CTD |
PMID:23593118 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
En1 |
engrailed homeobox 1 |
decreases expression |
ISO |
Malathion results in decreased expression of EN1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:31,750,892...31,756,477
Ensembl chr13:31,751,545...31,755,943
|
|
G |
Enkur |
enkurin, TRPC channel interacting protein |
increases expression |
ISO |
Malathion results in increased expression of ENKUR mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408
|
|
G |
Epha10 |
EPH receptor A10 |
increases expression |
ISO |
Malathion results in increased expression of EPHA10 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:137,139,588...137,175,637
Ensembl chr 5:137,140,735...137,174,157
|
|
G |
Epha4 |
Eph receptor A4 |
increases expression |
ISO |
Malathion results in increased expression of EPHA4 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
decreases expression |
ISO |
Malathion results in decreased expression of EPHX1 mRNA |
CTD |
PMID:17311802 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Epop |
elongin BC and polycomb repressive complex 2 associated protein |
increases expression |
ISO |
Malathion results in increased expression of EPOP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912
|
|
G |
Eps8l1 |
EPS8-like 1 |
increases expression |
ISO |
Malathion results in increased expression of EPS8L1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:69,343,202...69,359,778
Ensembl chr 1:69,344,243...69,363,524
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
increases expression |
ISO |
Malathion results in increased expression of ERBB4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases activity |
ISO |
Malathion results in decreased activity of ESR1 protein |
CTD |
PMID:22562034 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
increases expression |
ISO |
Malathion results in increased expression of ETV6 mRNA mutant form |
CTD |
PMID:28624474 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
ISO |
Malathion results in increased expression of F3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fam124a |
family with sequence similarity 124 member A |
increases expression |
ISO |
Malathion results in increased expression of FAM124A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:36,799,836...36,855,062
Ensembl chr15:36,799,877...36,853,683
|
|
G |
Fam227b |
family with sequence similarity 227, member B |
decreases expression |
ISO |
Malathion results in decreased expression of FAM227B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:113,226,662...113,392,396
Ensembl chr 3:113,233,205...113,392,320
|
|
G |
Fam229b |
family with sequence similarity 229, member B |
decreases expression |
ISO |
Malathion results in decreased expression of FAM229B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:42,538,853...42,552,355
Ensembl chr20:42,538,868...42,552,248
|
|
G |
Fgf22 |
fibroblast growth factor 22 |
decreases expression |
ISO |
Malathion results in decreased expression of FGF22 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:9,947,632...9,956,918
Ensembl chr 7:9,948,071...9,950,486
|
|
G |
Fgf6 |
fibroblast growth factor 6 |
increases expression |
ISO |
Malathion results in increased expression of FGF6 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 4:159,854,913...159,863,447
Ensembl chr 4:159,854,913...159,863,447
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
increases expression |
ISO |
Malathion results in increased expression of FGFBP1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
increases expression |
ISO |
Malathion results in increased expression of FGFR1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
Malathion results in decreased expression of FGG mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Filip1l |
filamin A interacting protein 1-like |
increases expression |
ISO |
Malathion results in increased expression of FILIP1L mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:42,937,353...43,177,085
Ensembl chr11:42,940,467...43,177,415
|
|
G |
Flt4 |
Fms related receptor tyrosine kinase 4 |
increases expression |
ISO |
Malathion results in increased expression of FLT4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression increases methylation multiple interactions |
EXP |
Malathion results in decreased expression of FOXO1 mRNA Malathion results in increased methylation of FOXO1 promoter [Malathion results in increased methylation of FOXO1 promoter] which results in decreased expression of FOXO1 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo4 |
forkhead box O4 |
increases expression |
ISO |
Malathion results in increased expression of FOXO4 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr X:66,385,241...66,392,115
Ensembl chr X:66,385,558...66,392,115
|
|
G |
Fshr |
follicle stimulating hormone receptor |
increases expression |
ISO |
Malathion results in increased expression of FSHR mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions increases activity |
EXP |
[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein; Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein] Malathion results in increased activity of G6PD protein |
CTD |
PMID:27214522 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
affects binding |
ISO |
Malathion binds to [GAD1 protein binds to Pyridoxal Phosphate]; Malathion binds to GAD1 protein |
CTD |
PMID:35151785 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
affects binding |
ISO |
Malathion binds to [GAD2 protein binds to Pyridoxal Phosphate]; Malathion binds to GAD2 protein |
CTD |
PMID:35151785 |
|
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
increases expression |
ISO |
Malathion results in increased expression of GALNT16 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Garin2 |
golgi associated RAB2 interactor family member 2 |
decreases expression |
ISO |
Malathion results in decreased expression of GARIN2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:97,489,562...97,534,729
Ensembl chr 6:97,490,368...97,534,763
|
|
G |
Gas2 |
growth arrest-specific 2 |
increases expression |
ISO |
Malathion results in increased expression of GAS2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gata4 |
GATA binding protein 4 |
decreases expression |
ISO |
Malathion results in decreased expression of GATA4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gbp1 |
guanylate binding protein 1 |
increases expression |
ISO |
Malathion results in increased expression of GBP1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gbp3 |
guanylate binding protein 3 |
increases expression |
ISO |
Malathion results in increased expression of GBP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:231,460,032...231,500,266
Ensembl chr 2:231,486,062...231,493,098
|
|
G |
Gbp5 |
guanylate binding protein 5 |
increases expression |
ISO |
Malathion results in increased expression of GBP5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061
|
|
G |
Gk |
glycerol kinase |
multiple interactions increases activity |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased activity of GK protein] |
CTD |
PMID:25449180 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gk2 |
glycerol kinase 2 |
decreases expression |
EXP |
Malathion results in decreased expression of GK2 mRNA |
CTD |
PMID:25449180 |
|
NCBI chr14:12,107,071...12,108,923
Ensembl chr14:12,107,020...12,128,473
|
|
G |
Gmnc |
geminin coiled-coil domain containing |
increases expression |
ISO |
Malathion results in increased expression of GMNC mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:73,836,255...73,847,698
Ensembl chr11:73,814,533...73,847,328
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
increases expression |
ISO |
Malathion results in increased expression of GNAI1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
decreases expression |
ISO |
Malathion results in decreased expression of GNAI2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions increases activity |
EXP |
thymoquinone inhibits the reaction [Malathion results in increased activity of GOT1 protein] |
CTD |
PMID:33510276 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Got1l1 |
glutamic-oxaloacetic transaminase 1-like 1 |
increases expression |
ISO |
Malathion results in increased expression of GOT1L1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:64,860,308...64,873,656
Ensembl chr16:64,860,704...64,866,162
|
|
G |
Gp5 |
glycoprotein V (platelet) |
increases expression |
ISO |
Malathion results in increased expression of GP5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gpr179 |
G protein-coupled receptor 179 |
decreases expression |
ISO |
Malathion results in decreased expression of GPR179 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:82,324,568...82,340,448
Ensembl chr10:82,337,771...82,340,448
|
|
G |
Gps2 |
G protein pathway suppressor 2 |
decreases expression |
ISO |
Malathion results in decreased expression of GPS2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:54,637,360...54,640,542
Ensembl chr10:54,637,455...54,640,650
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
Malathion results in increased activity of GPT protein thymoquinone inhibits the reaction [Malathion results in increased activity of GPT protein] |
CTD |
PMID:25180440 PMID:33510276 PMID:36370973 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gramd4 |
GRAM domain containing 4 |
decreases expression |
ISO |
Malathion results in decreased expression of GRAMD4 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 7:117,150,398...117,224,056
Ensembl chr 7:117,150,374...117,224,053
|
|
G |
Grk1 |
G protein-coupled receptor kinase 1 |
increases expression |
ISO |
Malathion results in increased expression of GRK1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:76,122,501...76,135,792
Ensembl chr16:76,123,842...76,135,792
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression |
EXP |
Malathion results in increased expression of GSK3B mRNA |
CTD |
PMID:25449180 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions decreases activity |
ISO EXP |
[Hexachlorocyclohexane co-treated with Malathion] results in decreased activity of GSR protein zinc chloride inhibits the reaction [Malathion results in decreased activity of GSR protein] |
CTD |
PMID:16718366 PMID:19429256 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
Malathion results in decreased expression of GSTP1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gzmb |
granzyme B |
decreases expression multiple interactions |
ISO |
Malathion results in decreased expression of GZMB protein Plant Extracts inhibits the reaction [Malathion results in decreased expression of GZMB protein]; Polyphenols inhibits the reaction [Malathion results in decreased expression of GZMB protein] |
CTD |
PMID:32120800 |
|
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
increases expression |
ISO |
Malathion results in increased expression of H19 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Has1 |
hyaluronan synthase 1 |
increases expression |
ISO |
Malathion results in increased expression of HAS1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
Malathion results in increased expression of HBEGF mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hdc |
histidine decarboxylase |
affects binding |
ISO |
Malathion binds to [HDC protein binds to Pyridoxal Phosphate]; Malathion binds to HDC protein |
CTD |
PMID:35151785 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hilpda |
hypoxia inducible lipid droplet-associated |
increases expression |
ISO |
Malathion results in increased expression of HILPDA mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
Malathion results in increased expression of HMOX1 protein |
CTD |
PMID:34778934 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnmt |
histamine N-methyltransferase |
decreases expression |
ISO |
Malathion results in decreased expression of HNMT mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
ISO |
[Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA Malathion results in increased expression of HRAS mRNA; Malathion results in increased expression of HRAS protein |
CTD |
PMID:18204794 PMID:19787260 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions decreases expression |
ISO EXP |
lavender oil inhibits the reaction [Malathion results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:30409133 PMID:36336997 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsf2bp |
heat shock transcription factor 2 binding protein |
increases expression |
ISO |
Malathion results in increased expression of HSF2BP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242
|
|
G |
Hspb2 |
heat shock protein family B (small) member 2 |
increases expression |
ISO |
Malathion results in increased expression of HSPB2 protein |
CTD |
PMID:19607909 |
|
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
decreases expression |
ISO |
Malathion results in decreased expression of HTATIP2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Htra4 |
HtrA serine peptidase 4 |
decreases expression |
ISO |
Malathion results in decreased expression of HTRA4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression |
ISO |
Malathion results in increased expression of IDO1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
increases expression |
ISO |
Malathion results in increased expression of IFI44L mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
Malathion inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] |
CTD |
PMID:18177342 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
decreases expression multiple interactions increases expression |
EXP ISO |
Malathion results in decreased expression of IFNG protein Plant Extracts inhibits the reaction [Malathion results in decreased expression of IFNG protein]; Polyphenols inhibits the reaction [Malathion results in decreased expression of IFNG protein] Malathion results in increased expression of IFNG mRNA Acetylcysteine inhibits the reaction [Malathion results in increased expression of IFNG mRNA]; Taurine inhibits the reaction [Malathion results in increased expression of IFNG mRNA] |
CTD |
PMID:19145326 PMID:24810974 PMID:25180440 PMID:28987951 PMID:32120800 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il11 |
interleukin 11 |
increases expression |
ISO |
Malathion results in increased expression of IL11 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il13 |
interleukin 13 |
increases expression |
ISO |
Malathion results in increased expression of IL13 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
increases expression |
ISO |
Malathion results in increased expression of IL13RA2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Malathion results in increased expression of IL1A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL1B mRNA]; Taurine inhibits the reaction [Malathion results in increased expression of IL1B mRNA] |
CTD |
PMID:24810974 PMID:25180440 PMID:28987951 PMID:37047231 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
decreases expression |
EXP |
Malathion results in decreased expression of IL1R2 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
multiple interactions decreases expression |
ISO |
Plant Extracts inhibits the reaction [Malathion results in decreased expression of IL2 protein]; Polyphenols inhibits the reaction [Malathion results in decreased expression of IL2 protein] |
CTD |
PMID:32120800 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il23a |
interleukin 23 subunit alpha |
increases expression |
ISO |
Malathion results in increased expression of IL23A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Malathion results in increased expression of IL24 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il36g |
interleukin 36, gamma |
increases expression |
ISO |
Malathion results in increased expression of IL36G mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO |
Malathion results in decreased expression of IL4 protein Plant Extracts inhibits the reaction [Malathion results in decreased expression of IL4 protein]; Polyphenols inhibits the reaction [Malathion results in decreased expression of IL4 protein] |
CTD |
PMID:32120800 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP ISO |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of IL6 mRNA] |
CTD |
PMID:24810974 PMID:25180440 PMID:37047231 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhba |
inhibin subunit beta A |
increases expression decreases methylation |
ISO |
Malathion results in increased expression of INHBA mRNA Malathion results in decreased methylation of INHBA promoter |
CTD |
PMID:37047231 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ins1 |
insulin 1 |
increases expression |
EXP |
Malathion results in increased expression of INS1 protein |
CTD |
PMID:25449180 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
increases expression |
ISO |
Malathion results in increased expression of IRAK1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
increases expression |
ISO |
Malathion results in increased expression of IRAK2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
|
|
G |
Irx2 |
iroquois homeobox 2 |
increases expression |
ISO |
Malathion results in increased expression of IRX2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:30,660,960...30,666,378
Ensembl chr 1:30,660,960...30,666,378
|
|
G |
Itgb8 |
integrin subunit beta 8 |
decreases methylation increases expression |
ISO |
Malathion results in decreased methylation of ITGB8 promoter Malathion results in increased expression of ITGB8 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
|
|
G |
Kazn |
kazrin, periplakin interacting protein |
decreases expression |
ISO |
Malathion results in decreased expression of KAZN mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:154,392,793...155,381,567
Ensembl chr 5:154,392,793...154,779,074
|
|
G |
Kcnh5 |
potassium voltage-gated channel subfamily H member 5 |
increases expression |
ISO |
Malathion results in increased expression of KCNH5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
increases methylation decreases expression |
ISO |
Malathion results in increased methylation of KCNMA1 promoter Malathion results in decreased expression of KCNMA1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198
|
|
G |
Kif6 |
kinesin family member 6 |
decreases expression |
ISO |
Malathion results in decreased expression of KIF6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
increases expression multiple interactions |
EXP |
Malathion results in increased expression of KIT protein Rosmarinic Acid inhibits the reaction [Malathion results in increased expression of KIT protein]; thymoquinone inhibits the reaction [Malathion results in increased expression of KIT protein] |
CTD |
PMID:33510276 PMID:34262720 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
increases mutagenesis increases expression |
ISO |
Malathion results in increased mutagenesis of KMT2A gene Malathion results in increased expression of KMT2A mRNA mutant form |
CTD |
PMID:28624474 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Krt14 |
keratin 14 |
increases expression |
ISO |
Malathion results in increased expression of KRT14 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt17 |
keratin 17 |
increases expression |
ISO |
Malathion results in increased expression of KRT17 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
|
|
G |
Krtap27-1 |
keratin associated protein 27-1 |
increases expression |
ISO |
Malathion results in increased expression of KRTAP27-1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:27,980,875...27,982,002
|
|
G |
L1td1 |
LINE-1 type transposase domain containing 1 |
affects expression multiple interactions increases methylation |
EXP |
Malathion affects the expression of L1TD1 mRNA [Malathion results in increased methylation of L1TD1 promoter] which affects the expression of L1TD1 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 5:113,373,193...113,386,088
Ensembl chr 5:113,379,870...113,385,730
|
|
G |
Lat |
linker for activation of T cells |
increases expression |
EXP |
Malathion results in increased expression of LAT mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
|
|
G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
increases expression |
ISO |
Malathion results in increased expression of LCORL mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
|
|
G |
Lemd1 |
LEM domain containing 1 |
increases expression |
ISO |
Malathion results in increased expression of LEMD1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
|
|
G |
Lgals1 |
galectin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of LGALS1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression |
ISO |
Malathion results in increased expression of LIF mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lin28b |
lin-28 homolog B |
increases expression |
ISO |
Malathion results in increased expression of LIN28B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:48,865,329...48,964,769
Ensembl chr20:48,869,485...48,955,077
|
|
G |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
decreases expression |
ISO |
Malathion results in decreased expression of LINGO1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:57,011,272...57,193,496
Ensembl chr 8:57,010,007...57,196,544
|
|
G |
Lmbr1 |
limb development membrane protein 1 |
increases expression |
ISO |
Malathion results in increased expression of LMBR1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:5,974,687...6,146,348
Ensembl chr 4:5,974,750...6,146,368
|
|
G |
LOC120095955 |
mucin-12-like |
decreases expression |
ISO |
Malathion results in decreased expression of MUC12 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr12:19,486,041...19,493,995
|
|
G |
Lpcat4 |
lysophosphatidylcholine acyltransferase 4 |
increases expression |
ISO |
Malathion results in increased expression of LPCAT4 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 3:99,044,729...99,052,963
Ensembl chr 3:99,044,729...99,052,875
|
|
G |
Lrguk |
leucine-rich repeats and guanylate kinase domain containing |
decreases expression |
ISO |
Malathion results in decreased expression of LRGUK mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:62,647,222...62,770,268
Ensembl chr 4:62,647,264...62,770,319
|
|
G |
Lrp3 |
LDL receptor related protein 3 |
decreases expression |
ISO |
Malathion results in decreased expression of LRP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:87,843,815...87,859,147
Ensembl chr 1:87,844,868...87,859,110
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
decreases expression |
ISO |
Malathion results in decreased expression of LYPD1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
increases expression |
ISO |
Malathion results in increased expression of LZTS1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Lzts2 |
leucine zipper tumor suppressor 2 |
decreases expression |
ISO |
Malathion results in decreased expression of LZTS2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:243,876,665...243,888,489
Ensembl chr 1:243,880,022...243,888,423
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
decreases expression |
ISO |
Malathion results in decreased expression of MACROD2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
decreases expression |
ISO |
Malathion results in decreased expression of MAP2K3 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Marchf3 |
membrane associated ring-CH-type finger 3 |
increases expression |
ISO |
Malathion results in increased expression of MARCHF3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
|
|
G |
Mbp |
myelin basic protein |
decreases expression |
ISO |
Malathion results in decreased expression of MBP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
multiple interactions increases expression |
ISO |
[Malathion co-treated with Estrogens] results in increased expression of MCM2 mRNA Malathion results in increased expression of MCM2 mRNA |
CTD |
PMID:18204794 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Meis1 |
Meis homeobox 1 |
decreases expression |
ISO |
Malathion results in decreased expression of MEIS1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
increases expression |
ISO |
Malathion results in increased expression of MET mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
ISO |
Malathion results in increased expression of MFSD2A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mill1 |
MHC I like leukocyte 1 |
increases expression |
ISO |
Malathion results in increased expression of MICA mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
Malathion results in increased expression of MMP1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
increases expression |
ISO |
Malathion results in increased expression of MMP10 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression |
ISO |
Malathion results in increased expression of MMP12 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Malathion results in increased expression of MMP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases activity |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased activity of MPO protein] |
CTD |
PMID:24810974 PMID:25180440 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
decreases expression |
ISO |
Malathion results in decreased expression of COX1 mRNA |
CTD |
PMID:18214912 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
decreases expression |
ISO |
Malathion results in decreased expression of COX3 mRNA |
CTD |
PMID:18214912 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
Malathion results in increased expression of MT1E mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
Malathion results in increased expression of MT2A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mybphl |
myosin binding protein H-like |
increases expression |
ISO |
Malathion results in increased expression of MYBPHL mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:196,005,297...196,018,826
Ensembl chr 2:196,005,325...196,018,824
|
|
G |
Myo1b |
myosin Ib |
increases expression |
ISO |
Malathion results in increased expression of MYO1B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:49,690,043...49,852,373
Ensembl chr 9:49,690,086...49,850,798
|
|
G |
Myzap |
myocardial zonula adherens protein |
increases expression |
ISO |
Malathion results in increased expression of MYZAP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:72,155,817...72,243,036
Ensembl chr 8:72,131,530...72,243,036
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
decreases expression |
ISO |
Malathion results in decreased expression of NDUFS7 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression increases expression |
EXP |
Malathion affects the expression of NEFH mRNA Malathion results in increased expression of NEFH mRNA |
CTD |
PMID:22954530 PMID:28385489 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nek10 |
NIMA-related kinase 10 |
decreases expression |
ISO |
Malathion results in decreased expression of NEK10 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr15:10,387,063...10,564,177
Ensembl chr15:10,381,140...10,559,722
|
|
G |
Neu4 |
neuraminidase 4 |
increases expression |
ISO |
Malathion results in increased expression of NEU4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:94,396,920...94,402,576
Ensembl chr 9:94,396,920...94,402,576
|
|
G |
Neurl3 |
neuralized E3 ubiquitin protein ligase 3 |
increases expression |
ISO |
Malathion results in increased expression of NEURL3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
Malathion results in increased activity of NFE2L2 protein |
CTD |
PMID:30114225 PMID:30203046 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfib |
nuclear factor I/B |
decreases expression |
ISO |
Malathion results in decreased expression of NFIB mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
Malathion promotes the reaction [NGF protein results in increased expression of CAMK2A mRNA]; Malathion promotes the reaction [NGF protein results in increased expression of CAMK2B mRNA] |
CTD |
PMID:28385489 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Ninj1 |
ninjurin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of NINJ1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
decreases expression |
ISO |
Malathion results in decreased expression of NNT mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
EXP |
Malathion results in increased expression of NOS2 mRNA |
CTD |
PMID:20233601 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Malathion results in increased expression of NQO1 mRNA |
CTD |
PMID:17311802 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases expression increases activity |
ISO |
Malathion results in increased expression of NR1I3 mRNA Malathion results in increased activity of NR1I3 protein |
CTD |
PMID:22310298 PMID:28927721 PMID:30203046 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
increases expression |
ISO |
Malathion results in increased expression of NR4A1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
decreases methylation increases expression |
ISO |
Malathion results in decreased methylation of NR4A3 promoter Malathion results in increased expression of NR4A3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Ntn1 |
netrin 1 |
increases expression |
ISO |
Malathion results in increased expression of NTN1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
increases expression |
ISO |
Malathion results in increased expression of NTRK2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Ocln |
occludin |
multiple interactions decreases expression |
EXP |
[Malathion co-treated with Lead] results in decreased expression of OCLN protein Malathion results in decreased expression of OCLN protein |
CTD |
PMID:20970449 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Ocstamp |
osteoclast stimulatory transmembrane protein |
increases expression |
ISO |
Malathion results in increased expression of OCSTAMP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:154,131,113...154,141,611
Ensembl chr 3:154,132,328...154,136,991
|
|
G |
Odam |
odontogenic, ameloblast associated |
decreases expression |
ISO |
Malathion results in decreased expression of ODAM mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:20,193,286...20,202,517
Ensembl chr14:20,193,302...20,202,517
|
|
G |
Odf2l |
outer dense fiber of sperm tails 2-like |
decreases expression |
ISO |
Malathion results in decreased expression of ODF2L mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:234,036,049...234,072,751
Ensembl chr 2:234,033,652...234,072,747
|
|
G |
Olr1433 |
olfactory receptor 1433 |
increases expression |
ISO |
Malathion results in increased expression of OR2W3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:43,042,427...43,046,293
Ensembl chr10:43,037,857...43,046,701
|
|
G |
Olr1523 |
olfactory receptor 1523 |
decreases expression |
ISO |
Malathion results in decreased expression of OR4D1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:72,708,272...72,709,213
Ensembl chr10:72,707,063...72,715,311
|
|
G |
Olr35 |
olfactory receptor 35 |
decreases expression |
ISO |
Malathion results in decreased expression of OR2AT4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:153,994,678...154,043,281
Ensembl chr 1:154,041,306...154,043,257
|
|
G |
Omg |
oligodendrocyte-myelin glycoprotein |
affects expression |
ISO |
Malathion affects the expression of OMG mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:64,461,350...64,464,084
Ensembl chr10:64,461,350...64,464,084
|
|
G |
Opn5 |
opsin 5 |
decreases expression |
ISO |
Malathion results in decreased expression of OPN5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:18,368,393...18,416,098
Ensembl chr 9:18,368,416...18,415,476
|
|
G |
Or4f7b |
olfactory receptor family 4 subfamily F member 7B |
decreases expression |
ISO |
Malathion results in decreased expression of OR4F29 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:98,388,815...98,394,276
Ensembl chr 3:98,387,865...98,395,686
|
|
G |
Or4f7c |
olfactory receptor family 4 subfamily F member 7C |
decreases expression |
ISO |
Malathion results in decreased expression of OR4F21 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:98,458,889...98,459,827
Ensembl chr 3:98,457,871...98,464,794
|
|
G |
Or6c2 |
olfactory receptor family 6 subfamily C member 2 |
decreases expression |
ISO |
Malathion results in decreased expression of OR6C2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:2,188,601...2,189,539
|
|
G |
Or9g4 |
olfactory receptor family 9 subfamily G member 4 |
decreases expression |
ISO |
Malathion results in decreased expression of OR9G4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:70,727,963...70,728,901
Ensembl chr 3:70,726,935...70,732,439
|
|
G |
P2rx1 |
purinergic receptor P2X 1 |
increases expression |
EXP |
Malathion results in increased expression of P2RX1 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr10:57,618,586...57,633,648
Ensembl chr10:57,618,586...57,633,623
|
|
G |
Palmd |
palmdelphin |
decreases expression |
ISO |
Malathion results in decreased expression of PALMD mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
Malathion results in increased cleavage of PARP1 protein Metoclopramide inhibits the reaction [Malathion results in increased cleavage of PARP1 protein] |
CTD |
PMID:29027213 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pax1 |
paired box 1 |
increases expression |
ISO |
Malathion results in increased expression of PAX1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 3:134,792,330...134,801,637
Ensembl chr 3:134,789,182...134,801,636
|
|
G |
Pcdh15 |
protocadherin related 15 |
decreases expression |
ISO |
Malathion results in decreased expression of PCDH15 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719
|
|
G |
Pcdhb19 |
protocadherin beta 19 |
decreases expression |
ISO |
Malathion results in decreased expression of PCDHB12 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:29,204,838...29,207,646
|
|
G |
Pcdhgb1 |
protocadherin gamma subfamily B, 1 |
increases expression |
ISO |
Malathion results in increased expression of PCDHGB1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:29,501,739...29,508,024
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of PCK1 mRNA] |
CTD |
PMID:25449180 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression |
ISO |
Atropine inhibits the reaction [Malathion results in increased expression of PCNA] |
CTD |
PMID:12762645 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde6c |
phosphodiesterase 6C |
decreases expression |
ISO |
Malathion results in decreased expression of PDE6C mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:235,909,583...235,965,435
Ensembl chr 1:235,909,775...235,965,315
|
|
G |
Pdia2 |
protein disulfide isomerase family A, member 2 |
decreases expression |
ISO |
Malathion results in decreased expression of PDIA2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:15,215,824...15,218,937
Ensembl chr10:15,215,824...15,220,931
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
decreases expression |
ISO |
Malathion results in decreased expression of PEBP1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
|
|
G |
Peg10 |
paternally expressed 10 |
increases expression |
ISO |
Malathion results in increased expression of PEG10 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
|
|
G |
Pfn1 |
profilin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of PFN1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of PHB1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Pitx1 |
paired-like homeodomain 1 |
decreases expression |
ISO |
Malathion results in decreased expression of PITX1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
|
|
G |
Plat |
plasminogen activator, tissue type |
decreases expression |
ISO |
Malathion results in decreased expression of PLAT mRNA |
CTD |
PMID:16079077 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Plau |
plasminogen activator, urokinase |
increases expression |
ISO |
Malathion results in increased expression of PLAU mRNA |
CTD |
PMID:32069766 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
increases expression |
ISO |
Malathion results in increased expression of PLAUR mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plcb4 |
phospholipase C, beta 4 |
increases expression |
ISO |
Malathion results in increased expression of PLCB4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
|
|
G |
Plekhd1 |
pleckstrin homology and coiled-coil domain containing D1 |
decreases expression |
ISO |
Malathion results in decreased expression of PLEKHD1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:100,340,655...100,371,942
Ensembl chr 6:100,340,655...100,371,941
|
|
G |
Plin1 |
perilipin 1 |
increases expression |
ISO |
Malathion results in increased expression of PLIN1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
|
|
G |
Plin2 |
perilipin 2 |
increases expression |
ISO |
Malathion results in increased expression of PLIN2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plp1 |
proteolipid protein 1 |
decreases expression |
ISO |
Malathion results in decreased expression of PLP1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
|
|
G |
Pls3 |
plastin 3 |
increases expression |
ISO |
Malathion results in increased expression of PLS3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
|
|
G |
Plvap |
plasmalemma vesicle associated protein |
decreases expression |
ISO |
Malathion results in decreased expression of PLVAP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:18,184,985...18,197,301
Ensembl chr16:18,184,975...18,197,301
|
|
G |
Pml |
PML nuclear body scaffold |
decreases expression |
ISO |
Malathion results in decreased expression of PML mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
ISO |
Malathion results in decreased expression of PPARA mRNA |
CTD |
PMID:25689681 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Prkd1 |
protein kinase D1 |
increases expression |
ISO |
Malathion results in increased expression of PRKD1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042
|
|
G |
Prox2 |
prospero homeobox 2 |
decreases expression |
ISO |
Malathion results in decreased expression of PROX2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:104,731,385...104,758,619
Ensembl chr 6:104,733,002...104,742,093
|
|
G |
Proz |
protein Z, vitamin K-dependent plasma glycoprotein |
decreases expression |
ISO |
Malathion results in decreased expression of PROZ mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:76,450,013...76,463,558
Ensembl chr16:76,450,013...76,463,480
|
|
G |
Ptcra |
pre T-cell antigen receptor alpha |
decreases expression |
ISO |
Malathion results in decreased expression of PTCRA mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:14,218,907...14,229,141
Ensembl chr 9:14,218,802...14,229,235
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Malathion results in increased expression of PTGS2 mRNA; Malathion results in increased expression of PTGS2 protein |
CTD |
PMID:30673264 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pygl |
glycogen phosphorylase L |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [Malathion results in increased expression of PYGL mRNA] |
CTD |
PMID:25449180 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
Rab11fip3 |
RAB11 family interacting protein 3 |
increases expression |
ISO |
Malathion results in increased expression of RAB11FIP3 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Rab3c |
RAB3C, member RAS oncogene family |
decreases expression |
ISO |
Malathion results in decreased expression of RAB3C mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:41,627,720...41,843,541
Ensembl chr 2:41,627,720...41,843,749
|
|
G |
Rapgef5 |
Rap guanine nucleotide exchange factor 5 |
increases expression |
ISO |
Malathion results in increased expression of RAPGEF5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:138,445,184...138,679,943
Ensembl chr 6:138,437,991...138,679,936
|
|
G |
Rbp3 |
retinol binding protein 3 |
decreases expression |
ISO |
Malathion results in decreased expression of RBP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:9,267,538...9,276,006
Ensembl chr16:9,267,538...9,276,006
|
|
G |
Rbp7 |
retinol binding protein 7 |
decreases expression |
ISO |
Malathion results in decreased expression of RBP7 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:159,889,723...159,894,338
Ensembl chr 5:159,889,723...159,894,339
|
|
G |
Redic1 |
regulator of DNA class I crossover intermediates 1 |
decreases expression |
ISO |
Malathion results in decreased expression of REDIC1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:122,318,495...122,386,002
Ensembl chr 7:122,318,499...122,385,983
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions |
EXP ISO |
Malathion results in increased expression of RELA mRNA Taurine inhibits the reaction [Malathion results in increased expression of RELA mRNA] |
CTD |
PMID:28987951 PMID:30673264 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Reln |
reelin |
increases expression |
ISO |
Malathion results in increased expression of RELN mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:12,736,177...13,162,956
Ensembl chr 4:12,736,130...13,162,211
|
|
G |
Rfc3 |
replication factor C subunit 3 |
decreases expression |
ISO |
Malathion results in decreased expression of RFC3 mRNA |
CTD |
PMID:16079077 |
|
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
|
|
G |
Rft1 |
RFT1 homolog |
decreases expression |
ISO |
Malathion results in decreased expression of RFT1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:5,827,063...5,861,120
Ensembl chr16:5,827,088...5,861,120
|
|
G |
Rhoa |
ras homolog family member A |
decreases activity |
ISO |
Malathion results in decreased activity of RHOA protein |
CTD |
PMID:37270087 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rhox13 |
Rhox homeobox family member 13 |
increases expression |
ISO |
Malathion results in increased expression of RHOXF1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:116,911,226...116,917,758
Ensembl chr X:116,911,329...116,917,644
|
|
G |
Rimbp2 |
RIMS binding protein 2 |
decreases expression |
ISO |
Malathion results in decreased expression of RIMBP2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr12:27,747,615...27,946,256
Ensembl chr12:27,747,980...27,956,763
|
|
G |
Rnase6 |
ribonuclease A family member 6 |
increases expression |
EXP |
Malathion results in increased expression of RNASE6 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr15:24,354,305...24,357,289
Ensembl chr15:24,354,303...24,357,328
|
|
G |
Rnf170 |
ring finger protein 170 |
increases expression |
ISO |
Malathion results in increased expression of RNF170 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:65,928,886...65,954,092
Ensembl chr16:65,928,895...65,954,083
|
|
G |
Rnf183 |
ring finger protein 183 |
increases expression |
ISO |
Malathion results in increased expression of RNF183 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:75,877,111...75,886,253
Ensembl chr 5:75,876,003...75,886,191
|
|
G |
Robo4 |
roundabout guidance receptor 4 |
decreases expression |
ISO |
Malathion results in decreased expression of ROBO4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:37,119,953...37,133,887
Ensembl chr 8:37,119,988...37,132,519
|
|
G |
Rph3a |
rabphilin 3A |
decreases expression |
ISO |
Malathion results in decreased expression of RPH3A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr12:35,542,389...35,618,901
Ensembl chr12:35,542,728...35,617,592
|
|
G |
Rrad |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
ISO |
Malathion results in increased expression of RRAD mRNA |
CTD |
PMID:37047231 |
|
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
|
|
G |
Rs1 |
retinoschisin 1 |
increases expression |
ISO |
Malathion results in increased expression of RS1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:33,962,440...33,992,203
Ensembl chr X:33,963,657...33,992,115
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
increases expression |
ISO |
Malathion results in increased expression of RSAD2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rspo2 |
R-spondin 2 |
decreases expression |
ISO |
Malathion results in decreased expression of RSPO2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:74,096,378...74,239,398
Ensembl chr 7:74,103,090...74,238,933
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
decreases expression |
ISO |
Malathion results in decreased expression of HLA-E mRNA |
CTD |
PMID:32069766 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
decreases expression |
ISO |
Malathion results in decreased expression of HLA-A mRNA |
CTD |
PMID:32069766 |
|
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
increases expression |
ISO |
Malathion results in increased expression of RUNX1 mRNA mutant form |
CTD |
PMID:28624474 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
S100a1 |
S100 calcium binding protein A1 |
decreases expression |
ISO |
Malathion results in decreased expression of S100A1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
|
|
G |
Scg5 |
secretogranin V |
increases expression |
ISO |
Malathion results in increased expression of SCG5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463
|
|
G |
Scn9a |
sodium voltage-gated channel alpha subunit 9 |
decreases expression |
ISO |
Malathion results in decreased expression of SCN9A mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
|
|
G |
Serpinb2 |
serpin family B member 2 |
increases expression |
ISO |
Malathion results in increased expression of SERPINB2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Sftpb |
surfactant protein B |
decreases expression multiple interactions |
ISO EXP |
Malathion results in decreased expression of SFTPB mRNA Malathion results in decreased expression of SFTPB mRNA; Malathion results in decreased expression of SFTPB protein Rosmarinic Acid inhibits the reaction [Malathion results in decreased expression of SFTPB protein]; thymoquinone inhibits the reaction [Malathion results in decreased expression of SFTPB mRNA] |
CTD |
PMID:33510276 PMID:34262720 PMID:37047231 |
|
NCBI chr 4:104,359,303...104,368,439
Ensembl chr 4:104,359,396...104,368,436
|
|
G |
Sgpp2 |
sphingosine-1-phosphate phosphatase 2 |
increases expression |
ISO |
Malathion results in increased expression of SGPP2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:79,762,658...79,884,665
Ensembl chr 9:79,763,284...79,880,457
|
|
G |
Shc1 |
SHC adaptor protein 1 |
increases expression |
ISO |
Malathion results in increased expression of SHC1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Shisa3 |
shisa family member 3 |
increases expression |
ISO |
Malathion results in increased expression of SHISA3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr14:40,563,672...40,568,244
Ensembl chr14:40,563,673...40,568,244
|
|
G |
Shisa9 |
shisa family member 9 |
increases expression |
ISO |
Malathion results in increased expression of SHISA9 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:3,335,616...3,629,334
Ensembl chr10:3,337,979...3,627,773
|
|
G |
Shtn1 |
shootin 1 |
decreases expression |
ISO |
Malathion results in decreased expression of SHTN1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:258,121,966...258,225,861
Ensembl chr 1:258,121,968...258,228,265
|
|
G |
Slc14a1 |
solute carrier family 14 member 1 (Kidd blood group) |
decreases expression |
ISO |
Malathion results in decreased expression of SLC14A1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Malathion inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:23770354 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Malathion inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:21561794 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc4a5 |
solute carrier family 4 member 5 |
decreases expression |
ISO |
Malathion results in decreased expression of SLC4A5 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:115,710,101...115,810,330
Ensembl chr 4:115,725,592...115,810,323
|
|
G |
Slco4a1 |
solute carrier organic anion transporter family, member 4a1 |
increases expression |
ISO |
Malathion results in increased expression of SLCO4A1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:167,559,177...167,578,307
Ensembl chr 3:167,559,316...167,578,305
|
|
G |
Smim32 |
small integral membrane protein 32 |
decreases expression |
ISO |
Malathion results in decreased expression of SMIM32 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:7,853,492...7,857,235
|
|
G |
Snca |
synuclein alpha |
increases expression multiple interactions |
EXP |
Malathion results in increased expression of SNCA mRNA; Malathion results in increased expression of SNCA protein crocin inhibits the reaction [Malathion results in increased expression of SNCA mRNA]; crocin inhibits the reaction [Malathion results in increased expression of SNCA protein]; Levodopa inhibits the reaction [Malathion results in increased expression of SNCA mRNA]; Levodopa inhibits the reaction [Malathion results in increased expression of SNCA protein] |
CTD |
PMID:35274200 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sntg1 |
syntrophin, gamma 1 |
decreases expression |
ISO |
Malathion results in decreased expression of SNTG1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:9,980,550...10,794,666
Ensembl chr 5:9,981,115...10,791,181
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression |
ISO |
Malathion results in decreased expression of SOCS3 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases activity decreases expression multiple interactions |
EXP ISO |
Malathion results in increased activity of SOD1 protein Malathion results in decreased expression of SOD1 protein lavender oil inhibits the reaction [Malathion results in decreased expression of SOD1 protein] alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD1 protein] |
CTD |
PMID:20194575 PMID:30409133 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions decreases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein]; Malathion results in increased expression of and results in increased activity of SOD2 protein lavender oil inhibits the reaction [Malathion results in decreased expression of SOD2 protein] |
CTD |
PMID:20194575 PMID:30409133 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spata17 |
spermatogenesis associated 17 |
decreases expression |
ISO |
Malathion results in decreased expression of SPATA17 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr13:98,605,986...98,784,855
Ensembl chr13:98,605,986...98,784,929
|
|
G |
Spdya |
speedy/RINGO cell cycle regulator family member A |
increases expression |
ISO |
Malathion results in increased expression of SPDYA mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:23,905,574...23,954,926
Ensembl chr 6:23,910,223...23,954,850
|
|
G |
Spink13 |
serine peptidase inhibitor Kazal type 13 |
decreases expression |
ISO |
Malathion results in decreased expression of SPINK13 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:56,064,839...56,206,257
Ensembl chr18:56,064,839...56,206,257
|
|
G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
decreases expression |
ISO |
Malathion results in decreased expression of SPINK4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:56,043,936...56,064,841
Ensembl chr 5:55,981,624...56,064,795
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
decreases expression |
EXP |
Malathion results in decreased expression of SRSF5 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Sspo |
SCO-spondin |
decreases expression |
ISO |
Malathion results in decreased expression of SSPOP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:77,394,915...77,450,526
Ensembl chr 4:77,397,059...77,450,412
|
|
G |
Sst |
somatostatin |
decreases expression |
ISO |
Malathion results in decreased expression of SST mRNA |
CTD |
PMID:37047231 |
|
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
|
|
G |
Sstr2 |
somatostatin receptor 2 |
increases expression |
ISO |
Malathion results in increased expression of SSTR2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
|
|
G |
St6gal2 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 2 |
increases expression |
ISO |
Malathion results in increased expression of ST6GAL2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:9,181,744...9,274,161
Ensembl chr 9:9,182,399...9,269,697
|
|
G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
increases expression |
EXP |
Malathion results in increased expression of ST8SIA1 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 4:175,782,989...175,921,338
Ensembl chr 4:175,789,947...175,920,708
|
|
G |
St8sia4 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
increases expression |
ISO |
Malathion results in increased expression of ST8SIA4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:95,990,131...96,084,661
Ensembl chr 9:95,993,503...96,084,653
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
ISO |
Malathion results in decreased expression of STAR mRNA lavender oil inhibits the reaction [Malathion results in decreased expression of STAR mRNA] |
CTD |
PMID:30409133 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation |
EXP |
Malathion results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:34778934 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
decreases activity |
ISO |
Malathion results in decreased activity of STAT5B protein |
CTD |
PMID:30114225 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Stk36 |
serine/threonine kinase 36 |
decreases expression |
ISO |
Malathion results in decreased expression of STK36 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:76,176,922...76,204,423
Ensembl chr 9:76,176,920...76,204,422
|
|
G |
Stra6 |
signaling receptor and transporter of retinol STRA6 |
decreases expression |
ISO |
Malathion results in decreased expression of STRA6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
|
|
G |
Tcf7l1 |
transcription factor 7 like 1 |
increases expression |
ISO |
Malathion results in increased expression of TCF7L1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:104,680,734...104,846,086
Ensembl chr 4:104,680,739...104,845,287
|
|
G |
Tchhl1 |
trichohyalin-like 1 |
decreases expression |
ISO |
Malathion results in decreased expression of TCHHL1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:179,134,941...179,138,467
Ensembl chr 2:179,135,796...179,138,202
|
|
G |
Tdrd1 |
tudor domain containing 1 |
increases expression |
ISO |
Malathion results in increased expression of TDRD1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:255,871,939...255,919,222
Ensembl chr 1:255,875,887...255,915,871
|
|
G |
Tdrd6 |
tudor domain containing 6 |
increases expression |
ISO |
Malathion results in increased expression of TDRD6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 9:17,344,033...17,359,348
Ensembl chr 9:17,344,026...17,359,344
|
|
G |
Tdrp |
testis development related protein |
decreases expression |
ISO |
Malathion results in decreased expression of TDRP mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:75,624,047...75,652,635
Ensembl chr16:75,624,907...75,652,420
|
|
G |
Tek |
TEK receptor tyrosine kinase |
increases expression |
ISO |
Malathion results in increased expression of TEK mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
|
|
G |
Tet1 |
tet methylcytosine dioxygenase 1 |
affects expression |
EXP |
Malathion affects the expression of TET1 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
decreases expression |
EXP |
Malathion results in decreased expression of TET2 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
|
|
G |
Tet3 |
tet methylcytosine dioxygenase 3 |
affects expression |
EXP |
Malathion affects the expression of TET3 mRNA |
CTD |
PMID:36370973 |
|
NCBI chr 4:115,867,412...115,964,433
Ensembl chr 4:115,871,265...115,964,193
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
Malathion results in increased expression of TFPI2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
ISO |
Malathion results in increased expression of TFRC mRNA |
CTD |
PMID:32069766 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tg |
thyroglobulin |
decreases expression |
EXP |
Malathion results in decreased expression of TG mRNA; Malathion results in decreased expression of TG protein |
CTD |
PMID:29143548 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Tifab |
TIFA inhibitor |
decreases expression |
ISO |
Malathion results in decreased expression of TIFAB mRNA |
CTD |
PMID:37047231 |
|
NCBI chr17:8,433,406...8,436,541
Ensembl chr17:8,431,635...8,436,592
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
decreases expression |
EXP |
Malathion results in decreased expression of TIMP3 mRNA |
CTD |
PMID:19784758 |
|
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression |
EXP |
[Malathion co-treated with Lead] results in decreased expression of TJP1 protein Malathion results in decreased expression of TJP1 protein |
CTD |
PMID:20970449 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tjp2 |
tight junction protein 2 |
multiple interactions decreases expression |
EXP |
[Malathion co-treated with Lead] results in decreased expression of TJP2 protein Malathion results in decreased expression of TJP2 protein |
CTD |
PMID:20970449 |
|
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions increases expression |
ISO |
Plant Extracts inhibits the reaction [Malathion results in increased expression of TLR4 protein]; Polyphenols inhibits the reaction [Malathion results in increased expression of TLR4 protein] |
CTD |
PMID:32120800 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr8 |
toll-like receptor 8 |
increases expression |
ISO |
Malathion results in increased expression of TLR8 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tmem114 |
transmembrane protein 114 |
decreases expression |
ISO |
Malathion results in decreased expression of TMEM114 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr10:7,168,998...7,185,251
Ensembl chr10:7,169,746...7,185,251
|
|
G |
Tmem158 |
transmembrane protein 158 |
increases expression |
ISO |
Malathion results in increased expression of TMEM158 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
|
|
G |
Tmem241 |
transmembrane protein 241 |
decreases expression |
ISO |
Malathion results in decreased expression of TMEM241 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr18:3,168,072...3,318,340
Ensembl chr18:3,168,067...3,318,293
|
|
G |
Tmem65 |
transmembrane protein 65 |
increases expression |
ISO |
Malathion results in increased expression of TMEM65 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:90,336,997...90,378,930
Ensembl chr 7:90,274,142...90,379,474
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
EXP ISO |
Malathion results in increased expression of TNF mRNA Taurine inhibits the reaction [Malathion results in increased expression of TNF mRNA] |
CTD |
PMID:28987951 PMID:37047231 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
increases expression |
ISO |
Malathion results in increased expression of TNFAIP6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tnfaip8l3 |
TNF alpha induced protein 8 like 3 |
decreases expression |
ISO |
Malathion results in decreased expression of TNFAIP8L3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:54,413,503...54,455,512
Ensembl chr 8:54,414,457...54,500,079
|
|
G |
Tnfsf15 |
TNF superfamily member 15 |
affects expression |
ISO |
Malathion affects the expression of TNFSF15 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
|
|
G |
Tnip3 |
TNFAIP3 interacting protein 3 |
increases expression |
ISO |
Malathion results in increased expression of TNIP3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:94,867,258...94,908,780
Ensembl chr 4:94,811,097...94,907,605
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO EXP |
Atropine inhibits the reaction [Malathion results in increased expression of TP53 protein] Plant Extracts inhibits the reaction [Malathion results in increased expression of TRP53 protein]; Polyphenols inhibits the reaction [Malathion results in increased expression of TRP53 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA] Malathion results in increased expression of TP53 mRNA; Malathion results in increased expression of TP53 protein |
CTD |
PMID:12505448 PMID:12762645 PMID:18204794 PMID:19787260 PMID:21628957 PMID:32120800 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i3 |
tumor protein p53 inducible protein 3 |
increases expression multiple interactions |
ISO |
Malathion results in increased expression of TP53I3 mRNA [Malathion co-treated with Estrogens] results in increased expression of TP53I3 mRNA |
CTD |
PMID:18204794 |
|
NCBI chr 6:27,818,327...27,825,753
|
|
G |
Tpd52l3 |
TPD52 like 3 |
decreases expression |
ISO |
Malathion results in decreased expression of TPD52L3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:227,781,173...227,785,040
Ensembl chr 1:227,773,724...227,784,467
|
|
G |
Tpr |
translocated promoter region, nuclear basket protein |
increases expression |
ISO |
Malathion results in increased expression of TPR mRNA |
CTD |
PMID:32069766 |
|
NCBI chr13:62,424,312...62,487,502
Ensembl chr13:62,424,312...62,487,496
|
|
G |
Tram1l1 |
translocation associated membrane protein 1-like 1 |
increases expression |
ISO |
Malathion results in increased expression of TRAM1L1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 2:212,511,130...212,513,311
|
|
G |
Trim35 |
tripartite motif-containing 35 |
decreases expression |
ISO |
Malathion results in decreased expression of TRIM35 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr15:40,493,697...40,510,246
Ensembl chr15:40,493,755...40,510,240
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
increases expression |
EXP |
Malathion results in increased expression of TRPC1 mRNA; Malathion results in increased expression of TRPC1 protein |
CTD |
PMID:22674931 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
increases expression decreases expression |
EXP ISO |
Malathion results in increased expression of TRPC4 mRNA; Malathion results in increased expression of TRPC4 protein Malathion results in decreased expression of TRPC4 mRNA |
CTD |
PMID:22674931 PMID:37047231 |
|
NCBI chr 2:138,307,676...138,476,856
Ensembl chr 2:138,308,084...138,476,768
|
|
G |
Trpc5os |
TRPC5 opposite strand |
increases expression |
ISO |
Malathion results in increased expression of TRPC5OS mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:108,025,172...108,044,201
Ensembl chr X:108,024,924...108,046,581
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
decreases expression |
EXP |
Malathion results in decreased expression of TSHR protein |
CTD |
PMID:29143548 |
|
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
|
|
G |
Ttc9 |
tetratricopeptide repeat domain 9 |
decreases expression |
ISO |
Malathion results in decreased expression of TTC9 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 6:101,333,274...101,368,110
Ensembl chr 6:101,333,141...101,368,110
|
|
G |
Tusc2 |
tumor suppressor 2, mitochondrial calcium regulator |
decreases expression |
ISO |
Malathion results in decreased expression of TUSC2 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 8:108,236,838...108,240,056
Ensembl chr 8:108,236,838...108,240,056
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
increases expression |
ISO |
Malathion results in increased expression of TWIST1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Txnrd3 |
thioredoxin reductase 3 |
decreases expression |
ISO |
Malathion results in decreased expression of TXNRD3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:122,072,548...122,112,493
Ensembl chr 4:122,072,548...122,112,491
|
|
G |
Tyms |
thymidylate synthetase |
decreases expression |
ISO |
Malathion results in decreased expression of TYMS mRNA |
CTD |
PMID:16079077 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ubd |
ubiquitin D |
increases expression |
ISO |
Malathion results in increased expression of UBD mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Umodl1 |
uromodulin-like 1 |
increases expression |
ISO |
Malathion results in increased expression of UMODL1 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr20:9,027,751...9,087,133
Ensembl chr20:9,025,724...9,087,146
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
increases expression |
ISO |
Malathion results in increased expression of USP2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
|
|
G |
Usp27x |
ubiquitin specific peptidase 27, X-linked |
increases expression |
ISO |
Malathion results in increased expression of USP27X mRNA |
CTD |
PMID:37047231 |
|
NCBI chr X:15,123,620...15,126,855
Ensembl chr X:15,124,596...15,125,912
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
decreases expression |
ISO |
Malathion results in decreased expression of VHL mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
|
|
G |
Vpreb3 |
V-set pre-B cell surrogate light chain 3 |
increases expression |
ISO |
Malathion results in increased expression of VPREB3 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
|
|
G |
Wbp2nl |
WBP2 N-terminal like |
decreases expression |
ISO |
Malathion results in decreased expression of WBP2NL mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:113,814,793...113,831,974
Ensembl chr 7:113,814,992...113,831,333
|
|
G |
Wfdc6a |
WAP four-disulfide core domain 6A |
decreases expression |
ISO |
Malathion results in decreased expression of WFDC6 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 3:153,305,336...153,309,144
Ensembl chr 3:153,305,336...153,309,144
|
|
G |
Wipf3 |
WAS/WASL interacting protein family, member 3 |
decreases expression |
ISO |
Malathion results in decreased expression of WIPF3 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 4:83,550,075...83,629,929
Ensembl chr 4:83,550,468...83,629,386
|
|
G |
Wt1 |
WT1 transcription factor |
increases expression |
ISO |
Malathion results in increased expression of WT1 mRNA |
CTD |
PMID:32069766 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Xkr4 |
XK related 4 |
decreases expression |
ISO |
Malathion results in decreased expression of XKR4 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 5:15,896,818...16,297,733
Ensembl chr 5:15,895,863...16,282,962
|
|
G |
Zfp42 |
zinc finger protein 42 |
decreases expression |
ISO |
Malathion results in decreased expression of ZFP42 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr16:48,836,463...48,845,443
Ensembl chr16:48,836,648...48,845,401
|
|
G |
Zfpm2 |
zinc finger protein, multitype 2 |
increases expression |
ISO |
Malathion results in increased expression of ZFPM2 mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 7:71,678,658...72,116,209
Ensembl chr 7:71,678,880...72,116,205
|
|
G |
Zscan5b |
zinc finger and SCAN domain containing 5B |
decreases expression |
ISO |
Malathion results in decreased expression of ZSCAN5B mRNA |
CTD |
PMID:37047231 |
|
NCBI chr 1:67,666,684...67,674,238
Ensembl chr 1:67,666,691...67,674,238
|
|
|
|